Results 191 to 200 of about 475,892 (311)
The versatile CaO2@CuMOF@HAP nanohybrid demonstrates an outstanding MMP9/pH‐triggered release performance for sequential release of osteogenic growth peptide into deep‐seated tumor‐infiltrated bone destruction areas and dual ions into tumor cells, enabling efficient tumor‐associated osteolysis restoration and tumor elimination for more comprehensive ...
Lan Liu +8 more
wiley +1 more source
Pharmacokinetics and Safety of Fezolinetant in Women with Hepatic or Renal Impairment. [PDF]
Iwai M +8 more
europepmc +1 more source
ABSTRACT Triple‐negative breast cancer (TNBC) exhibits addiction to chronic endoplasmic reticulum (ER) stress, which sustains an aggressive metastatic phenotype through activation of the unfolded protein response (UPR). Here, we identify a previously unrecognized “ER‐stress addiction” axis in which the Hippo pathway effector TEAD4 directly ...
Yini Shang +9 more
wiley +1 more source
Application of individualized low-protein diet nursing for managing multiple myeloma patients with renal impairment. [PDF]
Ling X, Yu M.
europepmc +1 more source
Cortical blindness: A rare but dramatic complication following coronary angiography [PDF]
Franz, Wolfgang-M. +4 more
core +1 more source
Autoimmune Encephalitis in Acute Care—Pathology, Diagnosis, and Management
ABSTRACT Autoimmune encephalitis (AE) is characterized by immune‐mediated inflammation of the brain parenchyma, presenting with various neurological syndromes, including but not limited to seizures, altered consciousness, neuropsychiatric symptoms, and movement disorders.
Suneesh Thilak +9 more
wiley +1 more source
Risk factors for renal impairment in primary aldosteronism: a retrospective study. [PDF]
Qin S +10 more
europepmc +1 more source
Management of Proteinuria in Dogs and Cats with Chronic Kidney Disease [PDF]
Atkins +46 more
core +2 more sources
This system adopts a biomimetic phospholipid structure, covalently binding iNOS inhibitors, neuroprotective agent PCA and vitamin E derivatives through pH/ROS dual‐responsive bonds, and assembles them with Prussian blue nanozyme to form PBB@AHA. It can efficiently penetrate the blood‐brain barrier and simultaneously release multiple active components ...
Mengcheng Guo +9 more
wiley +1 more source
Effects of Hepatic or Renal Impairment on Pharmacokinetics of Fruquintinib. [PDF]
Gonzalez M +8 more
europepmc +1 more source

